
According to Validea's guru fundamental report, ABBVIE INC (ABBV) receives an 81% rating based on Pim van Vliet's Multi-Factor Investor model, which favors low volatility stocks with strong momentum and high net payout yields. While ABBV passes tests for market cap and standard deviation, it scores neutral on twelve minus one momentum and net payout yield, ultimately failing the final rank. Van Vliet's strategy focuses on the outperformance of low volatility stocks, detailed in his book "High Returns From Low Risk: A Remarkable Stock Market Paradox."
AbbVie Inc. (ABBV) has been evaluated by Validea using the Pim van Vliet Multi-Factor Investor model, which prioritizes low volatility stocks also exhibiting strong momentum and high net payout yields. According to the report, ABBV achieved an 81% rating under this model, a score that typically indicates some level of interest from the strategy and contributes to a positive per-ticker sentiment score of 0.5 for ABBV. As a large-cap growth stock in the Biotechnology & Drugs industry, ABBV successfully passed the model's criteria for market capitalization and standard deviation, aligning with the strategy's preference for low volatility. However, the company received neutral ratings for 'twelve minus one momentum' and 'net payout yield,' which are two other critical factors sought by this specific investment strategy. Consequently, despite the initial 81% score and positive sentiment signals, ABBV ultimately received a 'FAIL' for its final rank within this particular model, highlighting a divergence between certain favorable attributes and a complete fit with all of the strategy's stringent criteria. This evaluation occurs within the framework of Pim van Vliet's investment philosophy, which emphasizes the potential for low-risk, low-volatility stocks to deliver superior risk-adjusted returns.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment